国际简称:GLOB HEART 参考译名:全球心脏
主要研究方向:Medicine-Cardiology and Cardiovascular Medicine 非预警期刊 审稿周期: 5 Weeks
《全球心脏》(Global Heart)是一本由Elsevier Science & Technology出版的以Medicine-Cardiology and Cardiovascular Medicine为研究特色的国际期刊,发表该领域相关的原创研究文章、评论文章和综述文章,及时报道该领域相关理论、实践和应用学科的最新发现,旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊,近三年没有被列入预警名单。
Global Heart offers a forum for dialogue and education on research, developments, trends, solutions and public health programs related to the prevention and control of cardiovascular diseases (CVDs) worldwide, with a special focus on low- and middle-income countries (LMICs). Manuscripts should address not only the extent or epidemiology of the problem, but also describe interventions to effectively control and prevent CVDs and the underlying factors. The emphasis should be on approaches applicable in settings with limited resources.
Economic evaluations of successful interventions are particularly welcome. We will also consider negative findings if important. While reports of hospital or clinic-based treatments are not excluded, particularly if they have broad implications for cost-effective disease control or prevention, we give priority to papers addressing community-based activities. We encourage submissions on cardiovascular surveillance and health policies, professional education, ethical issues and technological innovations related to prevention.
Global Heart is particularly interested in publishing data from updated national or regional demographic health surveys, World Health Organization or Global Burden of Disease data, large clinical disease databases or registries. Systematic reviews or meta-analyses on globally relevant topics are welcome. We will also consider clinical research that has special relevance to LMICs, e.g. using validated instruments to assess health-related quality-of-life in patients from LMICs, innovative diagnostic-therapeutic applications, real-world effectiveness clinical trials, research methods (innovative methodologic papers, with emphasis on low-cost research methods or novel application of methods in low resource settings), and papers pertaining to cardiovascular health promotion and policy (quantitative evaluation of health programs.
CiteScore | SJR | SNIP | CiteScore 指数 | ||||||||||||||||
5.7 | 1.022 | 1.021 |
|
名词解释:CiteScore 是衡量期刊所发表文献的平均受引用次数,是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年(含计算年度)的被引次数除以该期刊近四年发表的文献数。例如,2022年的 CiteScore 计算方法为:2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量 注:文献类型包括:文章、评论、会议论文、书籍章节和数据论文。
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 3区 | CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 | 3区 |
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 4区 | CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 | 4区 |
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 4区 | CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 | 4区 |
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 3区 | CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 | 3区 |
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 4区 | CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 | 4区 |
Top期刊 | 综述期刊 | 大类学科 | 小类学科 | ||
否 | 否 | 医学 | 3区 | CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 | 3区 |
按JIF指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | 72 / 220 |
67.5% |
按JCI指标学科分区 | 收录子集 | 分区 | 排名 | 百分位 |
学科:CARDIAC & CARDIOVASCULAR SYSTEMS | SCIE | Q2 | 73 / 220 |
67.05% |
Biomedicine & Pharmacotherapy
中科院 2区 JCR Q1
Frontiers In Pharmacology
中科院 2区 JCR Q1
Frontiers In Public Health
中科院 3区 JCR Q2
Bmc Psychiatry
中科院 2区 JCR Q2
Bmc Neurology
中科院 3区 JCR Q3
Bmc Womens Health
中科院 3区 JCR Q2
Bmc Public Health
中科院 2区 JCR Q1
Social Science & Medicine
中科院 2区 JCR Q1
若用户需要出版服务,请联系出版商:2N, 6 OSBORNE ST, LONDON, ENGLAND, E1 6TD。